Currently viewing the category: "Big Pharma"
Stop acting surprised!  Can’t you see that the bigger a thing gets, the more corrupt it becomes?  Wake up!…and welcome to today’s medical industry.  Yes, the same medical industry that has brought us Quackwatch, medical ethics, and the healthcare monopoly–oh, that medical industry.  Yes, yes, yes…not the glorified one depicted in Grey’s Anatomy or the talk show circuit, but the real deal.  Oh you really don’t know?  Hmmm..all right, check it:Device manufacturing giant Medtronic, and doctors paid by the company to carry out research, are under investigation by the Senate Finance Committee to determine whether the company failed to report serious side effects from the bone-growth agent Infuse in clinical studies.

The product was introduced in 2002 to help bones heal after spinal surgery and has been used in about 500,000 patients.  Since its arrival on the market, it has also been linked to some cases of cancer, male sterility, throat swelling and leg pain.  Some doctors in the spinal community believe that a “small number, fewer than five” fatalities may have even resulted from its use, though no published data points to any deaths.

Medtronic, its paid researchers, and its practices were attacked by a prominent US medical journal, The Spine Journal, its authors alleging that they failed to report adverse events to the journals that publish them.  Through thirteen trials involving 780 patients, “industry-funded researchers did not report a single adverse advent involving Medtronic’s Infuse Bone Graft,” said the three US-based doctors that co-authored the review article.

The reviewers went on to point out that the paid researchers of “nearly all the trials had financial ties with the manufacturer, with investigators earning as much as $26 million per study.”  The product brings in about $900 million in annual revenues for Medtronic, according to US media.

In 2008, the US Food and Drug Administration (FDA) issued a public health notice about “life-threatening complications” associated with the product, also known as recombinant human Bone Morphogenetic Protein (rhBMP), when used in the upper or cervical spine.  According to the FDA:

“FDA has received at least 38 reports of complications during the last four years with the use of rhBMP in cervical spine fusion.  These complications were associated with swelling of neck and throat tissue, which resulted in compression of the airway and/or neurological structures in the neck. Some reports describe difficulty swallowing, breathing or speaking.”

Last week the Senate Finance Committee sent a letter to Medtronics asking it to “produce documents related to its controversial bone growth product Infuse.”  The senators raised concerns that the company knew of the adverse effects of Infuse but failed to report them.  Now why would a medical device company do that?  Here are $900 million reasons, which is the annual revenue brought in by Infuse.

Here’s the game, folks: Big Daddy medical device manufacturer invents product promising billions.  Doctors are hired to conduct research and make it look promising; they are compensated handsomely.  Adverse effects are…whoops…left out of publication, and research papers sent to journals.  Journals rave, FDA approves manufacture and sales to the ever trusting American, then world, markets.  Company makes beaucoup bucks, some people get sick, some die; company pays out restitution or go-away money; everybody happy.

Listen, I’m not a “medicine and Big Pharma are evil” kind of guy.  On the contrary, I believe strongly that both industries are invaluable to human life and progress.  However, anything that gets too big, gets corrupt; and modern medicine is not immune.  Bravo to to the doctors calling out Medtronic for its heinous practices.  They knew, and they hid, the truth–that deserves the highest punishment…whatever that is.

But don’t for a second think that as western medicine grows to its behemoth monstrosity that it is above influence, corruption and greed.  We all are.  The bigger we get, the more we think we are above the rules…and doing what’s right.  The medical industry is all of us, our potential unleashed.  Let us be the ones, then, to rein it in.

Ha ha ha…nothing like the naivety of youth.  Take medical students for example–they actually think they cannot be influenced by gifts or trips provided by pharmaceutical manufacturers.  Silly little doctors-to-be; it’s like one of my teachers in chiropractic college said, “You think you know exactly what you’ll do until you have trouble paying the rent, your daughter needs braces, and college for your son is right around the corner.”  Ha ha ha…exactly.

Researchers at Harvard Medical School analyzed published studies that included a total of 9,850 students at 76 medical schools in the United States. The investigators found that most of the students had some type of interaction with drug companies and that this contact increased during the clinical years, with up to 90% of clinical students receiving some form of marketing materials from drug makers.

Among the students queried, most believed there was no ethical problem in accepting gifts from drug companies. Their justifications included financial hardship or pointing out that most other medical students accepted such gifts.

Nearly two-thirds of the medical students claimed that drug company promotions, gifts or interactions with sales representatives did not affect their impartiality regarding drug makers and their products.

Yeah, everyone thinks they are above such influence.  I personally think commercials are useless against my steel will, but who’s the fool?  Bottom line: Drug companies wouldn’t waste their time and money on aggressive marketing if it didn’t work.  And going after medical students is a strong step toward successful indoctrination.  Heck, if it works for Coke and Pepsi with the pre-schoolers, why not for Big Pharma and the med-schoolers?

The drug companies have even begun to target their marketing efforts to individual doctors.  They can buy biographical data from the American Medical Association (AMA) and analyze individual doctors personal and prescribing habits.  They can learn which drugs doctors lean toward, and they can even find out a doctor’s taste in dining, hobbies and travel.  Imagine an all expenses paid trip to Hawaii, from your friendly neighborhood pharmaceutical company.  And you think you wouldn’t buckle…now who’s the fool?

Listen, marketing influences consumers…even doctors.  No matter how much a doctor thinks, as a scientist, he is above basic marketing techniques, truth is he is influenced like the rest of us.  One study showed that doctors’ prescribing rates doubled and tripled for certain drugs following an all-expenses paid trip.  But that was just coincidence.

Get smart, med students–you will be influenced by pharmaceutical marketing.  It’s not a problem as long it’s in the best interest of the patient, the public health and the person paying the bills.  Until your profession lays down some regulations limiting contact between med students and pharmaceutical sales reps, you’ll just have to humble yourself to the power of marketing…and keep mind of your post-contact habits.

Copyright © 2013 Dr. Nick Campos - All Rights Reserved.